Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

198.86
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
103.53
Today|||52-Week Range
200.00
+76.48%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close198.86
Today’s open199.70
Day’s range197.01 - 199.75
Volume280,671
Average volume (3 months)334,540
Market cap$8.8B
Dividend yield--
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+99.57%
Earnings growth (next 5 years)+41.50%
Revenue growth (last year)+35.13%
P/E ratio97.5
Price/Sales12.56
Price/Book19.28

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc0.000.00%
WSTWest Pharmaceutical ...0.000.00%
MASIMasimo Corp0.000.00%
IARTIntegra LifeSciences...0.000.00%
Data as of 4:01pm ET, 11/22/2017

Financials

Next reporting dateFebruary 1, 2018
EPS forecast (this quarter)$0.50
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts